<a href="https://chambers.com/legal-trends/cross-border-considerations-for-privacy-in-clinical-trials">Published in Chambers Expert Focus.</a> With the recent publication of our Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans discuss ongoing and developing EU and US perspectives on privacy considerations with respect to cross-border clinical trials.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Published in Chambers Expert Focus. With the recent publication of our Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans discuss ongoing and developing EU and US perspectives on privacy considerations with respect to cross-border clinical trials. See omnystudio.com/listener for privacy information.

<a href="https://chambers.com/legal-trends/cross-border-considerations-for-privacy-in-clinical-trials" rel="noopener noreferrer">Published in Chambers Expert Focus.</a> With the recent publication of our Cross-border Guide to Clinical Trials and Privacy, James Clark, Paula Gonzalez de Castejón and David Kopans discuss ongoing and developing EU and US perspectives on privacy considerations with respect to cross-border clinical trials.See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Cross-border considerations for privacy in clinical trials

In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.

Share Cross-border considerations for privacy in clinical trials

Sign up to save your podcasts

Cross-border considerations for privacy in clinical trials

Cross-border considerations for privacy in clinical trials